New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life’s unique antibody...
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis up...
New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) --...
Three iadademstat abstracts have been accepted for presentation at the upcoming ASH-2025 Annual MeetingPreliminary data from the ongoing Phase Ib...
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to...
Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made...
PALO ALTO, CA / ACCESS Newswire / November 4, 2025 / Bioz, Inc., the leader in turning scientific literature into...
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased...
Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the...
Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation TechnologyExpert consensus predicts integration of...
Health Union's enhanced research suite expands its core patient and caregiver offerings to fully incorporate HCP insights, optimize its unique...
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical...
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Macular Telangiectasia ORLANDO, FL / ACCESS Newswire...
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company...
Patented innovation powers adaptive data operations and accelerates commercial optimization for life sciences companies SANTA CLARA, Calif., Nov. 3, 2025...
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ...
BENTONVILLE, Ark., Nov. 3, 2025 /PRNewswire/ -- HFA, an employee-owned, nationally recognized architecture and engineering firm, today announced the acquisition of...
In this free webinar, learn how crystallization strategies can optimize API development and scale-up. Attendees will understand the importance of...
Orchestrated by the NavaX Super Agent, the Suite includes previously launched MedDRA Coding Agent and upcoming cross-domain Agents BOSTON, Nov. 3,...